Understanding Cenforce
Cenforce 25 mg is a sildenafil citrate formulation manufactured by Centurion Laboratories, designed for investigating phosphodiesterase type 5 (PDE5) enzyme inhibition mechanisms in controlled laboratory environments. Sildenafil citrate operates as a selective inhibitor of cyclic guanosine monophosphate-specific phosphodiesterase type 5, representing a well-characterised molecular target for vascular smooth muscle research. This pharmaceutical-grade compound enables researchers to examine nitric oxide-cyclic GMP signalling pathways and their downstream effects on cellular calcium regulation. Our Stroid UK Shop maintains rigorous quality standards for investigational compounds across multiple therapeutic classes.
Laboratory Applications
Research scientists utilise sildenafil citrate to investigate endothelial function, vascular reactivity, and smooth muscle cell physiology in experimental models. The compound’s mechanism involves competitive inhibition of PDE5, leading to elevated cyclic GMP concentrations and subsequent protein kinase G activation. Studies have examined sildenafil’s effects on pulmonary vascular resistance, cardiac output parameters, and endothelial nitric oxide synthase expression in various research contexts. Investigators studying cardiovascular pharmacology often incorporate this compound alongside other research chemicals from our sildenafil citrate collection to evaluate comparative PDE5 inhibition profiles. Research applications extend to examining drug-drug interactions, pharmacokinetic parameters, and tissue-specific distribution patterns in preclinical models. Scientists also investigate potential synergistic effects when combined with compounds from our selective androgen receptor modulator range or peptide research collection for comprehensive experimental protocols.
Technical Specifications
| Active Ingredient | Sildenafil Citrate |
|---|---|
| Strength | 25 mg per tablet |
| Manufacturer | Centurion Laboratories |
| CAS Number | 139755-83-2 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.7 g/mol |
| Storage Requirements | Room temperature, dry environment |
| Form | Oral tablet |
Research Compliance
This product is intended strictly for in-vitro research and laboratory analysis purposes only. Cenforce 25 mg is not approved for human consumption, clinical use, or any therapeutic applications. Researchers must ensure appropriate institutional oversight, safety protocols, and regulatory compliance when conducting studies with this compound. All experimental work should be performed by qualified personnel in suitable laboratory facilities with proper ventilation and safety equipment.
